FDA Adverse Event Injury Summary report: N

JUVEDERM (VOLUME/CONCENTRTATION UNK)

MDR report key: 3913236 · Received June 11, 2014

Report

Report Number
3005113652-2014-00245
Event Type
Injury
Date Received
June 11, 2014
Date of Event
May 17, 2014
Report Date
May 19, 2014
Manufacturer
ALLERGAN
Product Code
LMH
PMA / PMN Number
P050047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

FURTHER INFO FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADD'L INFO IS AVAILABLE AT THIS TIME. THE EVENT OF "ANGIOEDEMA, SWELLING, COULDN'T BREATHE" ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED THAT IMMEDIATELY AFTER INJECTION WITH JUVEDERM IN THE LIPS, THE PT EXPERIENCED "ANGIOEDEMA, SWELLING" AT THE INJECTION SITE, AS WELL AS "COULDN'T BREATHE." MEDROL DOSEPAK, BENADRYL, AND "STEROID INJECTION" WERE PROVIDED AS TREATMENT BY THE INJECTOR AT THAT TIME. THE PT WAS SUBSEQUENTLY ADMITTED TO THE HOSP THAT SAME DAY AND WAS TREATED WITH PEPCID, BENADRYL, PREDNISONE, AND :PEPCID IV." SYMPTOMS WERE ONGOING TWO DAYS LATER AT THE TIME OF REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
343843 JUVEDERM (VOLUME/CONCENTRTATION UNK) LMH ALLERGAN NA NI

Patients

Seq Age Sex Outcome Treatment
1 40 YR Hospitalization| R ASACOL| "ANTIDEPRESSANT"| CYMBALTA